Portfolio of Biotech Stocks: Second Portfolio

Here is a sample of 10 biotech stocks from the universe of biotechnology companies.


10 Biotech Stocks: Second Portfolio

Name and Returns

Symbol

Recent Prices

Audentes TherapeuticsBOLD
Aimmune TherapeuticsAIMT
AlkermesALKS
Ionis PharmaceuticalsIONS
Madrigal PharmaceuticalsMDCL
Neurocrine BiosciencesNBIX
RegenxbioRGNX
Sarepta TherapeuticsSRPT
Vanda PharmaceuticalsVNDA
Viking TherapueticsVKTX
Price charts from Alpha Vantage as of most recent close.


Portfolio Values


To inspect the performance of the Biotech Stocks: Second Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 5 stocks included in the portfolio computations are: ALKS, IONS, NBIX, SRPT and VNDA. The current value of the portfolio assumes that $2,000.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 5 stocks excluded from the portfolio computations because of insufficient price data are: BOLD, AIMT, MDCL, RGNX and VKTX.

The current value of a $10,000 investment is $19,909. The percent return is 99.09%. The annualized return is 14.77%.





Related Portfolios

Portfolio of Biotech Stock: First Portfolio

Portfolio of Biotech Stocks: Diabetes

Portfolio of Dividend-Paying Pharmaceutical Stocks

Portfolio of Stem Cell Stocks